Massimo Libra Selected Research

Hemorrhage

1/2019	Cancer-associated stroke: Pathophysiology, detection and management (Review).
1/2017	Bevacizumab in the treatment of NSCLC: patient selection and perspectives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimo Libra Research Topics

Disease

117	Neoplasms (Cancer) 01/2024 - 07/2003
24	Breast Neoplasms (Breast Cancer) 10/2023 - 11/2005
18	Melanoma (Melanoma, Malignant) 01/2024 - 09/2008
12	Urinary Bladder Neoplasms (Bladder Cancer) 05/2020 - 10/2015
10	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2004
10	Infections 01/2023 - 01/2005
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 09/2015
9	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 01/2006
7	Inflammation (Inflammations) 02/2023 - 09/2006
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 03/2004
6	Lymphoma (Lymphomas) 09/2020 - 07/2002
6	Ovarian Neoplasms (Ovarian Cancer) 09/2017 - 05/2003
4	Colonic Neoplasms (Colon Cancer) 01/2023 - 02/2003
4	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2019
4	Hypertension (High Blood Pressure) 01/2022 - 10/2015
4	Carcinoma (Carcinomatosis) 12/2019 - 05/2003
4	Carcinogenesis 01/2019 - 01/2006
3	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 03/2011
3	Mouth Neoplasms (Oral Cancer) 08/2022 - 01/2019
3	COVID-19 08/2020 - 01/2020
3	Disease Progression 01/2020 - 06/2018
3	Peripheral Arterial Disease 10/2016 - 02/2005
2	Dysbiosis 04/2024 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 01/2011
2	Lung Neoplasms (Lung Cancer) 04/2023 - 11/2016
2	Diarrhea 01/2023 - 01/2017
2	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 10/2015
2	Adenocarcinoma 01/2020 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 09/2019 - 05/2014
2	Neuroblastoma 08/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2008
17	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2022 - 01/2006
15	MicroRNAs (MicroRNA)IBA 08/2022 - 12/2011
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2006
10	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2018
9	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 02/2003
9	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 02/2005
8	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 01/2006
7	CytokinesIBA 10/2022 - 01/2006
7	ORALIT (ORS)IBA 12/2019 - 10/2015
6	Interleukin-6 (Interleukin 6)IBA 10/2022 - 09/2006
6	BerberineIBA 01/2022 - 12/2012
5	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2004
5	Transcription Factors (Transcription Factor)IBA 02/2022 - 05/2009
5	Glycogen Synthase Kinase 3IBA 01/2021 - 05/2014
5	EnzymesIBA 03/2016 - 09/2006
4	NF-kappa B (NF-kB)IBA 01/2023 - 07/2010
4	Monoclonal AntibodiesIBA 09/2019 - 01/2011
4	Tamoxifen FDA LinkGeneric 01/2018 - 01/2006
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 11/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 03/2011
4	AntigensIBA 01/2017 - 01/2005
4	MTOR InhibitorsIBA 11/2016 - 07/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016 - 09/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2023 - 09/2008
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023 - 09/2008
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023 - 01/2006
3	Lipocalin-2IBA 01/2022 - 03/2014
3	PlatinumIBA 12/2019 - 05/2003
3	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 09/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 05/2003
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2006
3	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 03/2008
3	Mineral Fibers (Mineral Fiber)IBA 05/2017 - 02/2009
3	CarcinogensIBA 05/2017 - 01/2014
3	Phosphotransferases (Kinase)IBA 01/2017 - 12/2009
3	OsteopontinIBA 03/2016 - 11/2005
3	ErbB Receptors (EGF Receptor)IBA 01/2016 - 03/2011
3	Messenger RNA (mRNA)IBA 01/2016 - 03/2004
3	C-Reactive ProteinIBA 01/2015 - 09/2006
3	Hormones (Hormone)IBA 07/2014 - 06/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2012 - 05/2009
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2023 - 06/2022
2	SurvivinIBA 11/2023 - 09/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 07/2010
2	TensinsIBA 01/2023 - 09/2008
2	Phosphatidylethanolamine Binding ProteinIBA 01/2023 - 10/2013
2	Mitogen-Activated Protein KinasesIBA 01/2023 - 03/2022
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2018
2	Circulating Tumor DNAIBA 08/2022 - 10/2019
2	raf KinasesIBA 02/2022 - 12/2009
2	PolyphenolsIBA 01/2022 - 02/2021
2	IronIBA 01/2022 - 03/2016
2	nutlin 3IBA 01/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 09/2021 - 09/2011
2	RNA (Ribonucleic Acid)IBA 06/2021 - 04/2005
2	AntibodiesIBA 01/2021 - 01/2016
2	IsoflavonesIBA 01/2021 - 05/2019
2	Vitamin D FDA LinkGeneric 12/2020 - 01/2017
2	VitaminsIBA 05/2020 - 01/2020
2	Estrogen ReceptorsIBA 01/2020 - 11/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 08/2012

Therapy/Procedure

62	Therapeutics 11/2023 - 05/2003
22	Drug Therapy (Chemotherapy) 01/2023 - 03/2004
10	Immunotherapy 01/2023 - 07/2003
8	Mediterranean Diet 02/2023 - 01/2017
5	Radiotherapy 01/2023 - 11/2011
3	Precision Medicine 08/2022 - 06/2016
3	Aftercare (After-Treatment) 01/2018 - 10/2012
2	Oral Diagnosis (Oral Examination) 01/2020 - 01/2019